ArticleiScience2024

Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies.

Tetsuya Inoue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.